+0.69% were up 4.9% in premarket trading on Friday, the day after the company received approval from the Food and Drug Administration (FDA) to market Uplizna to treat neuromyelitis optica spectrum disorder.Qualcomm Inc. shares rocket toward record highs in the extended session Wednesday after the chip company projects a big jump in profit and revenue in the current quarter thanks to a settlement with Chinese tech giant Huawei Technologies Co. Jaimy Lee is a health-care reporter for MarketWatch.